Ugur Shahin
BioNTech CEO: I think we will Need an Adapted Vaccine against COVID-19 because of Omicron
German biotech company BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, said its CEO Ugur Shahin, adding that despite the mutations, the vaccines must continue to protect people against serious illness.